Genomma Lab Announces Fourth Quarter & Full Year 2022 Financial Results Call and Webcast

News provided by

Genomma Lab Internacional, S.A.B. de C.V.

Jan 30, 2023, 11:37 ET

MEXICO CITY, Jan. 30, 2023 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), today announced that it will report its Fourth Quarter & Full Year 2022 results on Wednesday, February 22, 2023 after the Mexican Market (BMV) close. The company also announced that it will hold a conference call on February 23, 2023 at 11 a.m. ET to discuss its quarterly financial results.

Presenters
Mr. Jorge Luis Brake, Chief Executive Officer
Mr. Antonio Zamora, Chief Financial Officer
Mr. Marco Sparvieri, Chief Operations Officer

Date
Thursday, February 23, 2023

Time
11:00 a.m. ET / 10:00 a.m. CST (Mexico City Time)

Webcast
To register, please click here

About Genomma Lab Internacional
Genomma Lab Internacional, S.A.B. de C.V. is one of the leading pharmaceutical and personal care products companies in Mexico with an increasing international presence. Genomma Lab develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. Genomma Lab relies on the combination of a successful new product development process, a consumer-oriented marketing, a broad retail distribution network and a low-cost, highly flexible operating model.

Genomma Lab's shares are listed on the Mexican Stock Exchange under the ticker "LABB" (Bloomberg: LABB:MM).

Public Contact:
Investor Relations
T. +52 (55) 5081 0000
[email protected]

SOURCE Genomma Lab Internacional, S.A.B. de C.V.